Stuart Randle
Chairman en BEACON ROOFING SUPPLY, INC. .
Fortuna: 4 M $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Jeffrey Hackman | M | 62 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | 3 años |
Liam Kelly | M | 57 | 15 años | |
Edward Sullivan | M | - |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | 3 años |
Kirsten Flowers | F | 49 |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | 3 años |
James Sherblom | M | 68 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | 3 años |
Julian Francis | M | 57 | 5 años | |
Stephen Klasko | M | 70 | 16 años | |
Rima Simson | F | - | - | |
Daniel Logue | M | - | 20 años | |
Michael Campbell | M | - | 2 años | |
Sirshendu Roopom Banerjee | M | 48 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | 3 años |
John Yee | M | - |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | 2 años |
Andrew Krakauer | M | 69 | 6 años | |
Cameron Hicks | M | 59 | 11 años | |
Earl Newsome | M | 61 | 3 años | |
Jaewon Ryu | M | 50 | 1 años | |
Neal I. Muni | M | - |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | - |
Neena Patil | F | 49 | 2 años | |
Racquel Mason | F | 54 | 1 años | |
Christine Reddy | F | 55 | 3 años | |
Dominik Reterski | M | - | - | |
Binit Sanghvi | M | - | 3 años | |
Robert McLaughlin | M | 67 | 8 años | |
Carmelo Carrubba | M | - | 2 años | |
Barbara Finck | M | 77 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | - |
Douglas Young | M | 61 | 10 años | |
Alan Gershenhorn | M | 65 | 9 años | |
Karen T. Boylan | F | 52 | 11 años | |
Neil Novich | M | 69 | 12 años | |
John Heinmiller | M | 69 | 5 años | |
Candace Duncan | F | 70 | 9 años | |
Richard Frost | M | 72 | 12 años | |
Lawrence Keusch | M | - | - | |
Gretchen Haggerty | F | 68 | 8 años | |
Zachariah Jonasson | M | 52 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | - |
V. Lawlis | M | 72 |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | - |
Barbara Fast | F | 70 | 6 años | |
Melanie Housey Hart | F | 51 | 2 años | |
Jason Taylor | M | 52 | - | |
Dorothy Clarke | F | 59 | 1 años | |
C. Best | M | 52 | 24 años | |
Dan Worley | M | - | - | |
Matt Tomkin | M | - | 9 años | |
Greg Bloom | M | - | 42 años | |
Howard Cyr | M | - | 6 años | |
Michael Kryukov | M | - | 17 años | |
Jamie Samide | M | - | - | |
John Deren | M | - | 11 años | |
James Winters | M | - | 6 años | |
Gregg W. Winter | M | 59 | - | |
Thomas Powell | M | 62 | 13 años | |
Marie Hendrixson | F | - | 15 años | |
Stephen Balogun | M | - | - | |
Jay White | M | - | 3 años | |
John P. Massarelli | M | - | 18 años | |
Timothy Duffy | M | - | 12 años | |
Jonathan Bennett | M | 55 | 3 años | |
Michelle Fox | F | - | 11 años | |
Michael K. Durkin | M | - |
Cotting School
| - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael D. Dale | M | 64 | 2 años | |
Thomas D. Schmitz | M | 56 | 16 años | |
Benson Smith | M | 76 | 15 años | |
Christoph H. Westphal | M | 56 |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | 4 años |
John McCabe | M | 55 |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | 5 años |
Laurence G. Miller | M | 69 | 10 años | |
David R. Grace | M | 64 | 26 años | |
Robert Crane | M | 65 | 11 años | |
Paul M. Isabella | M | 68 | 12 años | |
William McVicar | M | 66 |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | 2 años |
Nathan Sleeper | M | 50 | 7 años | |
Michael M. Selzer | M | 71 |
Optobionics Corp.
Optobionics Corp. Electronic ComponentsElectronic Technology Optobionics Corp. develops artificial retina and related devices to restore vision for individuals afflicted with retinitis pigmentosa, age-related macular degeneration, and other outer retinal diseases that can lead to blindness. It was founded by Alan Y. Chow and Vincent Y. Chow in 1990. The company is headquartered in Naperville, IL. | 4 años |
Philip Knisely | M | 69 | 9 años | |
Daniel Moore | M | 63 | 6 años | |
Jack Edward Meyer | M | 80 | - | |
C. Eric Swank | M | 55 | 17 años | |
Jeffrey P. Black | M | 63 | 11 años | |
Frank Lonegro | M | 55 | 4 años | |
Rick C. Welker | M | - | 9 años | |
Roderick MacKinnon | M | 68 |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | 4 años |
William Wexler | M | 65 | 2 años | |
Paul S. Evans | M | 61 |
Specialized Health Products International, Inc.
Specialized Health Products International, Inc. Medical SpecialtiesHealth Technology Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT. | 8 años |
James Wilson | M | - | - | |
James W. Zug | M | 83 | 10 años | |
Joseph Nowicki | M | 62 | 7 años | |
George Babich | M | 72 | 18 años | |
Richard Packer | M | 66 | - | |
James J. Gaffney | M | 82 | 12 años | |
Peter M. Gotsch | M | 59 | 20 años | |
Wilson Sexton | M | 86 | 12 años | |
Timothy Barberich | M | 76 | 10 años | |
Sigismundus W. W. Lubsen | M | 80 | 23 años | |
William Roland Cook | M | 80 | 19 años | |
Patricia C. Barron | F | 81 | 19 años | |
Harold Yoh | M | 63 | 12 años | |
Keith Merrell | M | 78 |
Specialized Health Products International, Inc.
Specialized Health Products International, Inc. Medical SpecialtiesHealth Technology Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT. | 7 años |
Carl Berquist | M | 73 | - | |
Jeffrey Graves | M | 62 | 10 años | |
Jeffrey Capello | M | 69 |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | 3 años |
Jacob Elguicze | M | 51 | 15 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 99 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Stuart Randle
- Red Personal